Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software

IT & Software

Panther Biotechnology agrees to buy Alchemia Oncology Panther Biotechnology has entered into an agreement to acquire Alchemia Oncology, a wholly owned subsidiary of Alchemia Limited, an Australian biotechnology company listed on the Australian Stock Exchange (ACL).
Automation > IT & Software > News
BSN medical expand lymphoedema therapy solutions with FarrowMed acquisition BSN medical continues to strengthen its position as a market leading provider of lymphoedema therapy solutions by acquiring FarrowMed and its range of patented FarrowWrap and related compression garment technologies, which focus on the management of lymphoedema and venous disease.
Automation > IT & Software > News SteadyMed, Cardiome partner to commercialize PAH drug Trevyent outside US By PBR Staff Writer
US pharmaceutical firm SteadyMed has entered into an exclusive license and supply agreement with Canada-based Cardiome to commercialize Trevyent in certain regions outside the US if the drug is approved to treat pulmonary arterial hypertension (PAH), in such regions.
Automation > IT & Software > News
See more IT & Software news

Latest IT & Software News and Insight

View all IT & Software news or find news targeted to your interests
Pro Bono Bio gets $15m to accelerate the global launches of Flexiseq and Sequaderma
Pro Bono Bio, the world's leading nanotechnology company offering health and lifestyle products, has launched its North American operations with headquarters based in Toronto, Canada and secured $15m in funding to accelerate the global launches of Flexiseq and Sequaderma as well as help fund its ambitious research and development programs that continue to place Pro Bono Bio at the forefront of nanotechnology healthcare development.
Automation > IT & Software > News
PBM Capital invests in Xalud Therapeutics' gene therapy platform to treat neuro-inflammatory diseases
PBM Capital Group, a healthcare-focused private investment firm, announces an investment in Xalud Therapeutics. This round of financing will help support the company’s gene therapy platform targeting multiple neuro-inflammatory diseases.
Automation > IT & Software > News
JCR Pharmaceuticals selects Medidata’s cloud-based platform for to rare disease clinical research in Japan
Medidata (MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, announced that its cloud-based technology platform has been adopted by JCR Pharmaceuticals.
Automation > IT & Software > News
IMS Health, FMI to optimize targeting of precision therapies in oncology
IMS Health (IMS) and Foundation Medicine (FMI) announced a collaboration to advance the understanding and effectiveness of precision medicines for treating cancer.
Automation > IT & Software > News
Kite Pharma, bluebird bio to jointly advance second generation TCR cell therapy products
By PBR Staff Writer
US-based biopharmaceutical firm Kite Pharma has entered into a collaboration agreement with bluebird bio to jointly develop and commercialize second generation T cell receptor (TCR) product candidates to treat human papillomavirus (HPV)-associated cancers.
Automation > IT & Software > News
Benitec, ReNeuron extend research collaboration to develop cellular therapies
By PBR Staff Writer
Australian biotechnology firm Benitec Biopharma has introduced a new exploratory cellular therapy program including exosome-based delivery using its ddRNAi technology.
Automation > IT & Software > News
CDC Foundation, Pfizer and CDC to develop longitudinal data collection system for SCD
By PBR Staff Writer
The CDC Foundation is partnering with the US Centers for Disease Control and Prevention's (CDC) Division of Blood Disorders within the National Center on Birth Defects and Developmental Disabilities, the California Rare Disease Surveillance Program and Pfizer to collect, analyze and disseminate sickle cell information.
Automation > IT & Software > News
CellResearch gets new US patent approval for exclusive stem cell technology amidst new partnerships
CellResearch Corporation Pte, a Singaporean company that specializes in stem cell technology, has received approval for its latest patent on 6 May 2015 from the US Patent and Trademark Office (USPTO).
Automation > IT & Software > News
Emulate, Janssen partner to use organs-on-chips platform to predict human response in drug development process
Emulate, announced that it recently formed a research collaboration with Janssen Biotech, a Janssen Pharmaceutical Company of Johnson & Johnson (Janssen), to deploy Emulate’s Organs-on-Chips platform across certain Janssen programs to better predict the potential human response of drug candidates and improve the drug development process.
Automation > IT & Software > News
Hemostemix, LBI to explore applications of Hemostemix technology for restoring blood supply
Hemostemix, a clinical-stage autologous cell-therapy company, announced that it has entered into a research collaboration agreement with the Austria-based Ludwig Boltzmann Institute for Experimental and Clinical Traumatology (LBI) to explore applications of Hemostemix technology for restoring blood supply.
Automation > IT & Software > News
View all IT & Software news or find news targeted to your interests